Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 6/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28650100 | 0.91 | TDP1 (0.31) | TDP1 | |
| SCHEMBL28650804 | 0.86 | CA1 (0.36) | POLBTDP1ACHE | |
| SCHEMBL11348835 | 0.77 | CA1 (0.35) | ACHE | |
| SCHEMBL8948227 | 0.77 | CA1 (0.35) | ACHE | |
| SCHEMBL28812122 | 0.76 | NAAA (0.55) | ACHE | |
| SCHEMBL28685186 | 0.76 | NAAA (0.55) | ACHE | |
| SCHEMBL28387816 | 0.76 | NAAA (0.55) | ACHE | |
| Water SCHEMBL11884552 | 0.75 | CA1 (0.34) | ACHE | |
| Potassium Ion SCHEMBL28524609 | 0.73 | CA1 (0.35) | ACHE | |
| SCHEMBL11783391 | 0.71 | CA1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087745-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4732825-A1 | AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE | BRAIN Biotech AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | SYMRISE AG (DE) | 2026-04-09 | — | — | US | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2026-02-19 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| EP-4687810-A1 | PREPARATIONS COMPRISING HYDROXY PINACOLONE RETINOATE | Symrise AG (DE) | 2026-02-11 | — | — | EP | disclosed |
| EP-4110276-B1 | COMPOSITIONS COMPRISING ALKANEDIOLS | SYMRISE AG (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-12534685-B2 | Fragrance composition | SYMRISE AG (DE) | 2026-01-27 | — | — | US | disclosed |
| US-12503672-B2 | Rim block with improved scent performance | SYMRISE AG (DE) | 2025-12-23 | — | — | US | disclosed |
| WO-2022122136-A1 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | disclosed |
| WO-2022111829-A1 | ESSENTIAL OILS OF CITRUS FRUITS FOR USE AS MEDICAMENT FOR INDUCED, INCREASED AND/OR ACCELERATED AUTOPHAGY IN HUMAN KERATINOCYTES | SYMRISE AG (DE) | 2022-06-02 | — | — | WO | disclosed |
| US-20220168198-A1 | AN ANTIMICROBIAL MIXTURE | SYMRISE AG (DE) | 2022-06-02 | — | — | US | disclosed |
| EP-3993767-A1 | BLEND OF BEESWAX AND A LACTYLATE ESTER | Symrise AG (DE) | 2022-05-11 | — | — | EP | disclosed |
| EP-3986365-A1 | SURFACTANT CONTAINING FORMULATION OF PSEUDO-CERAMIDES | Symrise AG (DE) | 2022-04-27 | — | — | EP | disclosed |
| US-20220117881-A1 | A HAIR CARE COMPOSITION | SYMRISE AG (DE) | 2022-04-21 | — | — | US | disclosed |
| EP-3982910-A1 | A COOLING PREPARATION | Symrise AG (DE) | 2022-04-20 | — | — | EP | disclosed |
| WO-2022053140-A1 | SURFACTANT CONTAINING FORMULATION OF PSEUDO-CERAMIDES | SYMRISE AG (DE) | 2022-03-17 | — | — | WO | disclosed |
| US-20220071872-A1 | A LIQUID AND TRANSPARENT BLEND OF UV FILTERS | SYMRISE AG (DE) | 2022-03-10 | — | — | US | disclosed |
| US-20220047476-A1 | A METHOD FOR FIGHTING FEMALE BODY ODORS | SYMRISE AG (DE) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534685-B2 | Fragrance composition | NCLN, HCN2, TRPA1 | POLB 735/4885TDP1 3044/4885ACHE 1642/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | POLB 2297/4885TDP1 4601/4885ACHE 4308/4885 |
| US-20260047994-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | RBP4, LRAT, RARB | POLB 907/4885TDP1 2532/4885ACHE 2124/4885 |
| US-20220047476-A1 | A METHOD FOR FIGHTING FEMALE BODY ODORS | SHBG, C5, CUTA | POLB 843/4885TDP1 3557/4885ACHE 593/4885 |
| US-20220168198-A1 | AN ANTIMICROBIAL MIXTURE | TMSB10, FHIT, EBP | POLB 193/4885TDP1 2896/4885ACHE 2982/4885 |
| US-20260096978-A1 | A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS | PTGS2, PTGES2, PTGS1 | POLB 2132/4885TDP1 1237/4885ACHE 2154/4885 |
| US-20220071872-A1 | A LIQUID AND TRANSPARENT BLEND OF UV FILTERS | F2, F12, TYR | POLB 279/4885TDP1 2197/4885ACHE 3765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.